✦ LIBER ✦
4005 ORAL An open label randomized Phase II study of oral triple angiokinase inhibitor BIBF 1120 in Hormone Refractory Prostate Cancer (HRPC) patients who progressed after docetaxel
✍ Scribed by S. Oudard; C. Chevreau; A. Fléchon; K. Gunzer; N. Houédé; I. Krakowski; H. de Mont-Serrat; N. Rouyrre; R. Kaiser; J.P. Droz
- Book ID
- 118625915
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 57 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.